R&D ESMO25: On partnerships between pharma and diagnostic develo... Jane Li, Senior Director of Pharma CDx and CRO Partnership, Clinical Next Generation Sequencing Business, at Thermo Fisher Scientific discusses CDx.
R&D Bolstering CAR-T therapies by tackling CRS, with Teresa Whal... In interview with Teresa Whalen, the CEO of CytoAgents, a clinical-stage drug development company working on a treatment for cytokine release syndrome
R&D A different approach to obesity treatment, with Steffen-Seba... At LSX 2025, editor-in-chief Jonah Comstock connected with Dr Steffen Sebastian-Bolz, chief science officer at Aphaia Pharma.
R&D Why Regeneron is giving away sequencing “for free”, with Ali... Alison Fenney, executive director of strategic partnerships and business operations at Regeneron Genetics Center, discusses free genetic sequencing.
R&D Driving innovation through partnership at AstraZeneca, with ... Nikhil Mutyal, head of search and evaluation for respiratory and immunology at AstraZeneca, discusses partnership and external innovation at LSX.
R&D WeightWatchers’ Scott Honken on rethinking success in the ag... At HLTH Europe, Deep Dive editor Eloise McLennan sat down with Scott Honken, chief commercial officer at WeightWatchers.
News NICE backs Roche's non-Hodgkin lymphoma drug Columvi NICE backs NHS use of Roche's Columvi as a second-line therapy for a form of non-Hodgkin lymphoma affecting thousands of people in the UK each year.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.